Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

BASF's new ET antagonists described in patent literature

Sep. 16, 1999

Cypros receives additional notice of allowance concerning U.S. patent on Cordox

Sep. 16, 1999

Modulators of cGMP production in development at HMR

Sep. 15, 1999

BiDil combination therapy offers benefits for black CHF patients

Sep. 15, 1999

Promising data on Resten-NG presented at international cardiology conference

Sep. 15, 1999

Endothelin antagonists described by BMS for hypertension, etc.

Sep. 14, 1999

Nonimmunosuppressive cytokine synthesis inhibitor effective in murine model of septic shock

Sep. 14, 1999

Medinox's NOX-100 demonstrates potential as treatment of hemorrhagic shock

Sep. 13, 1999

Potent and selective, optically active alpha1-adrenoceptor ligands developed in Taiwan

Sep. 10, 1999

Allosteric adenosine receptor modulators described by Medco

Sep. 10, 1999

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...